Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Littelfuse
LFUS
$11.2B
| $5.22M | ﹤0.01% |
19,107
-6,882
| -26% | -$1.83M |
|
|
SHAC
2777
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
| $5.22M | ﹤0.01% |
536,338
+480,850
| +867% | +$4.65M |
|
2778
The Ensign Group
ENSG
$10.4B
| $5.21M | ﹤0.01% |
69,628
+14,969
| +27% | +$1.24M |
|
2779
Malibu Boats
MBUU
$541M
| $5.19M | ﹤0.01% |
74,218
+27,190
| +58% | +$2.04M |
|
2780
Columbia Financial
CLBK
$1.12B
| $5.19M | ﹤0.01% |
280,722
-109,260
| -28% | -$1.95M |
|
2781
CALL
Welltower
WELL
$169B
| $5.19M | ﹤0.01% |
+63,000
| New | +$5.41M |
|
|
BLUE
2782
DELISTED
bluebird bio
BLUE
| $5.18M | ﹤0.01% |
20,945
-11,121
| -35% | -$3.18M |
|
2783
Donaldson
DCI
$10.9B
| $5.18M | ﹤0.01% |
90,303
+43,390
| +92% | +$2.8M |
|
|
SSAAU
2784
DELISTED
Science Strategic Acquisition Corp. Alpha Unit
SSAAU
| $5.18M | ﹤0.01% |
520,736
-229,022
| -31% | -$2.28M |
|
2785
Adecoagro
AGRO
$1.44B
| $5.18M | ﹤0.01% |
573,551
-366,330
| -39% | -$3.44M |
|
2786
Fulton Financial
FULT
$4.66B
| $5.17M | ﹤0.01% |
338,183
+100,400
| +42% | +$1.55M |
|
|
FCAX.U
2787
DELISTED
Fortress Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant
FCAX.U
| $5.17M | ﹤0.01% |
527,110
+5,107
| +1% | +$50.8K |
|
2788
MaxCyte
MXCT
$112M
| $5.16M | ﹤0.01% |
+422,442
| New | +$6.37M |
|
2789
Revolution Medicines
RVMD
$39.9B
| $5.14M | ﹤0.01% |
186,971
+145,151
| +347% | +$4.22M |
|
|
KIIIU
2790
DELISTED
Kismet Acquisition Three Corp. Unit
KIIIU
| $5.14M | ﹤0.01% |
518,895
-90,345
| -15% | -$894K |
|
|
RMGC
2791
DELISTED
RMG Acquisition Corp. III Class A Ordinary Shares
RMGC
| $5.13M | ﹤0.01% |
527,162
-670,963
| -56% | -$6.52M |
|
2792
Seacoast Banking Corp of Florida
SBCF
$3.36B
| $5.12M | ﹤0.01% |
151,444
+14,525
| +11% | +$460K |
|
2793
Archrock
AROC
$6.27B
| $5.11M | ﹤0.01% |
619,739
-25,298
| -4% | -$203K |
|
2794
PUT
Plug Power
PLUG
$2.87B
| $5.11M | ﹤0.01% |
200,000
+50,000
| +33% | +$1.34M |
|
2795
Signet Jewelers
SIG
$3.61B
| $5.1M | ﹤0.01% |
64,611
-61,590
| -49% | -$4.52M |
|
2796
Amerant Bancorp
AMTB
$1.16B
| $5.1M | ﹤0.01% |
206,153
-23,293
| -10% | -$550K |
|
|
CIXX
2797
DELISTED
CI Financial Corp.
CIXX
| $5.1M | ﹤0.01% |
250,728
+150,015
| +149% | +$2.88M |
|
|
PRDS
2798
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $5.09M | ﹤0.01% |
511,883
-10,620
| -2% | -$106K |
|
2799
CALL
DuPont de Nemours
DD
$18.5B
| $5.09M | ﹤0.01% |
59,591
+56,086
| +1,600% | +$5.2M |
|
|
OMIC
2800
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $5.08M | ﹤0.01% |
15,140
+8,093
| +115% | +$4.15M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.